Local Health Board’s Response to the Challenges of Covid-19 The Coronavirus (COVID-19) pandemic triggered a global health crisis that prompted a cascade of challenges from early 2020 through to 2021, with its effects on the healthcare system still being faced to this day.
A Review of Capsule Formulations and Extended-release Pepsin Mechanisms ARGiP contacted Swansea University’s Healthcare Technology Centre (HTC) seeking support via the Accelerate Programme to consolidate the understanding of pepsin biology to aid in the development of a refined pepsin supplement for the company.
Silicon Coated Steel Microneedle Penetration and Drug Delivery Xobaderm is an antiaging focused company which integrates the use of microneedles to deliver compounds to the skin which aims to not just cover up the external signs of aging skin, but aiming to instead slow cellular aging.
Characterisation of Recombinant Human Procollagen ProColl has developed an innovative method of producing recombinant human procollagen (HPC), making it commercially and medically advantageous over the animal-derived collagen products currently available on the market.
Informing New Clinical Clusters Within Menopause Health & Her is a Welsh-based SME that has developed an online female health platform for women going through menopause.
Swansea University Partnership Develops New Micro Needle Applicator Innoture holds worldwide patents in the manufacture of microneedle patches, the only company that has increased the mass production of flexible base patches worldwide.
Iminosugars and the Immune Response System PhytoQuest approached Swansea University's Healthcare Technology Centre with an interest in the discovery and commercialisation of naturally occurring plant sugars, known as iminosugars, as food supplements with numerous health benefits.
